The study by genetic researchers can potentially eliminate the ever-present stigma and hesitation among women to undergo a physical breast examination and later mammography for diagnosis.
The new test works by detecting sFlt1 and PIGF -- two proteins in the blood that predict poor outcomes from preeclampsia with substantially better accuracy than the current methods.
The study by a team from University College London in the UK, published in Lancet eBioMedicine, analysed proteins in the blood of healthcare workers infected with SARS-CoV-2.
Hyderabad: Apollo Cancer Centres in collaboration with Datar Cancer Genetics, a cancer research company, on Wednesday announced the launch of a blood test that promises to detect breast cancers at early stages in asymptomatic individuals with high accuracy, which could help timely diagnosis and treatment. Essentially, the blood test known as EasyCheck-Breast, provides knowledge about […]
